Cargando…
Ivermectin for preventing and treating COVID‐19
BACKGROUND: Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) repl...
Autores principales: | Popp, Maria, Stegemann, Miriam, Metzendorf, Maria-Inti, Gould, Susan, Kranke, Peter, Meybohm, Patrick, Skoetz, Nicole, Weibel, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/ https://www.ncbi.nlm.nih.gov/pubmed/34318930 http://dx.doi.org/10.1002/14651858.CD015017.pub2 |
Ejemplares similares
-
Ivermectin for preventing and treating COVID‐19
por: Popp, Maria, et al.
Publicado: (2022) -
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges
por: Popp, Maria, et al.
Publicado: (2022) -
Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19
por: Reis, Stefanie, et al.
Publicado: (2022) -
Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19
por: Reis, Stefanie, et al.
Publicado: (2023) -
Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Reis, Stefanie, et al.
Publicado: (2021)